However, we classified the tumor biology based on the prescribed medication: luminal tumors were characterized by prescriptions of endocrine therapy, while Her2 status depended on prescriptions of trastuzumab or pertuzumab or related antibody-drug conjugates. Here, ERBB2 is linked to neoplasm.